Arca
Skip to content

Surfuse Ii Gel, Surfuse Ii Putty, Exfuse Ii Gel, Exfuse Ii Putty

Bone Grafting Material, Human Source. 510(k) K130235, from Hans Biomed Corp. (Chevy Chase, MD). Product code NUN, class 2.

As of Nov 17, 2026, K130235 is an FDA 510(k) held by Hans Biomed Corp., substantially equivalent on Jan 10, 2014 after 345 days, with no recalls tied to it in FDA's recall database.

  • Substantially equivalent: Jan 10, 2014
  • Review time: 345 days
  • Recalls: 0

Indications for Use

As the 510(k) summary states them, read from FDA's summary PDF

The SurFuse™ II Putty and ExFuse™ II Putty are bone filling materials indicated for dental intraosseous, oral and maxillofacial defects, including periodontal/infrabony defects; alveolar ridge augmentation; dental extraction sites; sinus lifts; cystic defects.

Predicate Devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Record

Type
Traditional
Received
Jan 30, 2013
Review panel
Dental
Regulation
21 CFR 872.3930

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.